HU210009B - Process for producing pharmaceutical compositions containing il-4, for treating non-hodgkin malignus limfoma - Google Patents

Process for producing pharmaceutical compositions containing il-4, for treating non-hodgkin malignus limfoma Download PDF

Info

Publication number: HU210009B
Authority: HU; Hungary
Prior art keywords: cell; cells; hodgkin; malignant; growth
Prior art date: 1990-12-13

Application number

HU9301719A

Other languages

English (en)

Hungarian (hu)

Other versions

HUT64478A (en

HU9301719D0 (en

Inventor

Jacques Banchereau

France Thierry De

Original Assignee

Schering Plough Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-13

Filing date

1991-12-10

Publication date

1995-01-30

1991-12-10 Application filed by Schering Plough Corp filed Critical Schering Plough Corp

1993-09-28 Publication of HU9301719D0 publication Critical patent/HU9301719D0/hu

1994-01-28 Publication of HUT64478A publication Critical patent/HUT64478A/hu

1995-01-30 Publication of HU210009B publication Critical patent/HU210009B/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cephalosporin Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HU9301719A 1990-12-13 1991-12-10 Process for producing pharmaceutical compositions containing il-4, for treating non-hodgkin malignus limfoma HU210009B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90403585A EP0490006B1 (en)	1990-12-13	1990-12-13	Pharmaceutical compositions for the treatment of B-cell malignancies

Publications (3)

Publication Number	Publication Date
HU9301719D0 HU9301719D0 (en)	1993-09-28
HUT64478A HUT64478A (en)	1994-01-28
HU210009B true HU210009B (en)	1995-01-30

Family

ID=8205785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9301719A HU210009B (en)	1990-12-13	1991-12-10	Process for producing pharmaceutical compositions containing il-4, for treating non-hodgkin malignus limfoma

Country Status (16)

Country	Link
EP (2)	EP0490006B1 (fi)
JP (1)	JPH06504767A (fi)
AT (1)	ATE135232T1 (fi)
AU (1)	AU9072191A (fi)
CA (1)	CA2098509A1 (fi)
CZ (1)	CZ113593A3 (fi)
DE (1)	DE69117974T2 (fi)
DK (1)	DK0561927T3 (fi)
ES (1)	ES2084995T3 (fi)
FI (1)	FI932650L (fi)
GR (1)	GR3019699T3 (fi)
HU (1)	HU210009B (fi)
IE (1)	IE64157B1 (fi)
OA (1)	OA09788A (fi)
SK (1)	SK59193A3 (fi)
WO (1)	WO1992010201A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2711182B2 (ja) *	1992-08-19	1998-02-10	シェリング・コーポレーション	Ｉｌ−４を用いるｈｉｖ複製を阻害する方法
US5679338A (en) *	1994-05-12	1997-10-21	Osteoarthritis Science, Inc.	Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) *	1994-09-07	1998-02-10	Schering Corporation	Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0552243B1 (en) *	1990-09-06	1996-11-27	Schering Corporation	Use of il-4 to treat solid tumors

1990
- 1990-12-13 EP EP90403585A patent/EP0490006B1/en not_active Expired - Lifetime
1991
- 1991-12-10 AU AU90721/91A patent/AU9072191A/en not_active Abandoned
- 1991-12-10 DK DK92901009.8T patent/DK0561927T3/da active
- 1991-12-10 EP EP92901009A patent/EP0561927B1/en not_active Expired - Lifetime
- 1991-12-10 AT AT92901009T patent/ATE135232T1/de not_active IP Right Cessation
- 1991-12-10 ES ES92901009T patent/ES2084995T3/es not_active Expired - Lifetime
- 1991-12-10 SK SK591-93A patent/SK59193A3/sk unknown
- 1991-12-10 WO PCT/EP1991/002380 patent/WO1992010201A1/en active IP Right Grant
- 1991-12-10 CZ CS931135A patent/CZ113593A3/cs unknown
- 1991-12-10 JP JP4501648A patent/JPH06504767A/ja active Pending
- 1991-12-10 CA CA002098509A patent/CA2098509A1/en not_active Abandoned
- 1991-12-10 HU HU9301719A patent/HU210009B/hu not_active IP Right Cessation
- 1991-12-10 DE DE69117974T patent/DE69117974T2/de not_active Expired - Fee Related
- 1991-12-12 IE IE432891A patent/IE64157B1/en not_active IP Right Cessation
1993
- 1993-06-10 FI FI932650A patent/FI932650L/fi not_active Application Discontinuation
- 1993-06-11 OA OA60382A patent/OA09788A/en unknown
1996
- 1996-04-22 GR GR960401082T patent/GR3019699T3/el unknown

Also Published As

Publication number	Publication date
GR3019699T3 (en)	1996-07-31
IE64157B1 (en)	1995-07-12
CZ113593A3 (en)	1994-01-19
FI932650A0 (fi)	1993-06-10
DE69117974D1 (de)	1996-04-18
FI932650L (fi)	1993-06-10
EP0490006B1 (en)	1994-06-22
DK0561927T3 (da)	1996-07-29
IE914328A1 (en)	1992-06-17
DE69117974T2 (de)	1996-07-25
ATE135232T1 (de)	1996-03-15
CA2098509A1 (en)	1992-06-14
EP0561927A1 (en)	1993-09-29
WO1992010201A1 (en)	1992-06-25
JPH06504767A (ja)	1994-06-02
ES2084995T3 (es)	1996-05-16
AU9072191A (en)	1992-07-08
EP0490006A1 (en)	1992-06-17
EP0561927B1 (en)	1996-03-13
SK59193A3 (en)	1994-01-12
HUT64478A (en)	1994-01-28
HU9301719D0 (en)	1993-09-28
OA09788A (en)	1994-04-15

Publication	Publication Date	Title
EP0787008B1 (en)	2009-01-07	Thymosin alpha1 in combination with a natural cytokine mixture for the treatment of a cellular immune deficiency
Bellone et al.	1995	Regulation of NK cell functions by TGF-beta 1.
Schwarz et al.	1989	Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic
US5382427A (en)	1995-01-17	Use of IL-4 to treat solid tumors
Elmslie et al.	1991	Interleukins: biological properties and therapeutic potential
Noma et al.	1984	Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin
EP0684828A1 (en)	1995-12-06	EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b)
HU210009B (en)	1995-01-30	Process for producing pharmaceutical compositions containing il-4, for treating non-hodgkin malignus limfoma
Sun et al.	2003	Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice
Miyazaki et al.	1991	Synergistic effect of Nocardia rubra cell wall skeleton and recombinant interleukin 2 for in vivo induction of lymphokine-activated killer cells
WO2012050829A2 (en)	2012-04-19	Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration
CHARAK et al.	1995	Augmentation of murine hematopoiesis by interleukin 2-activated irradiated T cells
Figdor et al.	1992	FUNCTION BY INTERLEUKIN-4
Wang et al.	1995	Effect of lymphocytes on the production of granulomonopoietic enhancing factor by fully mature macrophages
Cohen et al.	1985	Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice
Abrahamsen et al.	1992	Cytokines

Legal Events

Date	Code	Title	Description
1996-09-30	HMM4	Cancellation of final prot. due to non-payment of fee